Can Wegovy Cause Weight Gain — and If So, When?

You've started Wegovy and the scales have ticked up, here's why that sometimes happens

Picture the first few weeks after your initial injection. You expected the numbers on the scales to fall. Instead, they've barely moved, or have nudged upward by a kilogram or two. Before concluding Wegovy is working against you, it helps to know what is happening physiologically at this early stage.

Semaglutide slows gastric emptying, meaning food moves through your stomach more slowly than before. In the short term, this can cause the gut to hold more content than usual, showing up as a small temporary increase on a morning weigh-in. There can also be fluid retention shifts as eating patterns change. Neither of these is fat gain. They are transient physiological adjustments that typically resolve within the first few weeks as the body settles at the starter dose.

There is also the question of nausea. Many people eat less than they intend to during the early titration phase, then compensate as nausea eases. If calorie intake bounces back without appetite suppression fully kicking in, weight can briefly plateau or edge upward before the medicine's full effect becomes established. Gaining weight while taking Wegovy is genuinely possible in these first weeks, but it rarely signals a lasting pattern.

The NHS medicines information for semaglutide notes that nausea, vomiting, and diarrhoea are among the most commonly reported effects during dose escalation, and these GI changes are precisely the mechanism behind early-phase weight fluctuations, not evidence the treatment is failing.

Why the bigger risk is what happens after you stop

The scenario that clinical data shows more clearly is weight gain after Wegovy ends, not during treatment. The STEP 1 trial (68 weeks of semaglutide 2.4mg versus placebo, published in the New England Journal of Medicine) reported an average body weight reduction of around 15% during active treatment. A follow-up analysis showed that participants who stopped the medicine after the trial regained a substantial portion of that lost weight within about a year.

This happens because semaglutide works by activating GLP-1 receptors involved in appetite regulation and the feeling of fullness. When you stop taking it, those receptors lose their pharmacological stimulus. Hunger hormones that were being modulated gradually return towards their pre-treatment levels. Appetite comes back. The biological drive to regain weight reasserts itself.

This is not a reflection of willpower. Obesity is a chronic condition with a physiological basis, and the evidence base around weight regain after stopping Wegovy underlines why treatment decisions (including how long to continue, and what happens at the end) are worth discussing carefully with your prescriber rather than deciding alone.

Who might respond differently, and what that means practically

A minority of people on Wegovy do not see the expected weight loss, or find that weight creeps up even during treatment. Several factors can explain this. Medications taken alongside Wegovy (some antidepressants, corticosteroids, certain antipsychotics) can promote weight gain independently, and their effect can outpace the medicine's appetite-reducing action. Hormonal shifts, including perimenopause, can have the same effect.

Calorie intake also matters more than it might seem. Wegovy reduces appetite; it does not make dietary choices irrelevant. If someone adapts their eating habits to compensate for reduced hunger signals (eating larger portions later in the day, for instance), the net calorie balance can remain unchanged. If you have seen Wegovy ads that make the process look straightforward, it is worth knowing that individual responses vary considerably depending on these kinds of factors.

Sleep deprivation and high stress both elevate cortisol, which drives fat storage and hunger, particularly for calorie-dense foods. These are real clinical factors, not lifestyle lectures, and they are part of why every consultation involves a full picture of someone's health rather than just a BMI number. If you are considering Wegovy as part of a broader plan, our weight management overview sets out what the treatment journey typically looks like.

The short answer to whether Wegovy can cause weight gain is: rarely during active treatment, and almost never in the sense of causing true fat accumulation. The more clinically significant concern is what happens after stopping, and planning for that is part of responsible prescribing. Every patient at our pharmacy receives a clinical review before each repeat order, precisely so these questions are revisited as circumstances change.

If you want to understand how effectively Wegovy produces weight loss in the evidence base, or you are trying to work out whether this medicine suits your situation, starting a free consultation is the first step. A real prescriber (not an automated system) reviews your answers and makes a clinical judgement based on your full health picture. Our guide to gaining weight on Wegovy also explains the specific circumstances in which the scales can move in the wrong direction, and what to do if that happens. For a fuller overview of how semaglutide works, the semaglutide information page covers the mechanism and licence in detail.

One more practical note: if you do go ahead, what arrives is a discreet box from DPD (no branding on the outside) tracked to your door the next working day. The pen itself is pre-filled and ready to use once your prescriber confirms the appropriate starting dose.